These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2423701)

  • 1. Drastic immunoreactivity changes between the immature and mature forms of the Sendai virus HN and F0 glycoproteins.
    Mottet G; Portner A; Roux L
    J Virol; 1986 Jul; 59(1):132-41. PubMed ID: 2423701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular maturation of mumps virus hemagglutinin-neuraminidase glycoprotein: conformational changes detected with monoclonal antibodies.
    Waxham MN; Merz DC; Wolinsky JS
    J Virol; 1986 Aug; 59(2):392-400. PubMed ID: 3735488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of high-mannose sugars must precede disulfide bond formation for proper folding of Sendai virus glycoproteins.
    Vidal S; Mottet G; Kolakofsky D; Roux L
    J Virol; 1989 Feb; 63(2):892-900. PubMed ID: 2536110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus.
    Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M
    Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte reactivity with individual Sendai virus glycoproteins.
    Al-Ahdal MN; Nakamura I; Flanagan TD
    J Virol; 1985 Apr; 54(1):53-7. PubMed ID: 2983119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of the envelope glycoproteins of Newcastle disease virus on cellular membranes.
    Schwalbe JC; Hightower LE
    J Virol; 1982 Mar; 41(3):947-57. PubMed ID: 6284983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies specific for Sendai virus. I. Production and characterization of monoclonal antibodies.
    Fenner M; Binz H
    Scand J Immunol; 1986 Sep; 24(3):335-40. PubMed ID: 2428098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.
    Ray R; Compans RW
    Virology; 1986 Jan; 148(1):232-6. PubMed ID: 2417412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
    Anderson K; Stott EJ; Wertz GW
    J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive mutants of Newcastle disease virus altered in HN glycoprotein size, stability, or antigenic maturity.
    Peeples ME; Glickman RL; Gallagher JP; Bratt MA
    Virology; 1988 May; 164(1):284-9. PubMed ID: 3363869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of cytolytic T cells by isolated viral peptides and HN protein coupled to agarose beads.
    Guertin DP; Fan DP
    Nature; 1980 Jan; 283(5744):308-11. PubMed ID: 6153234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoproteins of Sendai virus: purification and antigenic analysis.
    Urata DM; Seto JT
    Intervirology; 1975-1976; 6(2):108-14. PubMed ID: 58850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus.
    Portner A; Scroggs RA; Metzger DW
    Virology; 1987 May; 158(1):61-8. PubMed ID: 2437698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homooligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity.
    Collins PL; Mottet G
    J Virol; 1991 May; 65(5):2362-71. PubMed ID: 1707981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three variations in the cell surface expression of the haemagglutinin-neuraminidase glycoprotein of Sendai virus.
    Roux L; Beffy P; Portner A
    J Gen Virol; 1985 May; 66 ( Pt 5)():987-1000. PubMed ID: 2987404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of monoclonal antibodies against the hemagglutinin-neuraminidase and fusion protein on the release of Sendai virus from infected cells.
    Orvell C; Kristensson K
    Arch Virol; 1985; 86(1-2):1-15. PubMed ID: 2994598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization of Sendai virus HN protein complexed with monoclonal antibody Fab fragments.
    Laver WG; Thompson SD; Murti KG; Portner A
    Virology; 1989 Jul; 171(1):291-3. PubMed ID: 2545033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some physico-chemical and biological properties of egg-Sendai virus with altered haemagglutinin-neuraminidase protein.
    Popa LM; Repanovici R; Iliescu R; Mihalache O; Cajal N
    Acta Virol; 1985 Dec; 29(6):461-5. PubMed ID: 2869656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 1 affects its functional but not its antigenic properties.
    Gorman WL; Pridgen C; Portner A
    Virology; 1991 Jul; 183(1):83-90. PubMed ID: 1647078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.